wrss2
Vaccineexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2013 (NCT01336699)
Timeline
Indications
Mechanism of action
- Shigella sonneiImmunity, active
Shigella sonnei immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- wrss2
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04242264 | Phase 2 | Feb 13, 2020 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT01336699 | Phase 1 | Jan 1, 2013 | National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 2 | 2 | 2 | 2013 |
1 organizations
Page 1 / 1